The addition of a GLP-1 RA to basal insulin instead of using traditional prandial insulin is now increasingly chosen based on similar hemoglobin A1C (HbA1C) reduction and the additional benefits of weight loss and reduced risk of hypoglycemia [8]. The gene discussed is INS; the disease is Hypoglycemia.